Dr Xu has been the Chief Executive Officer since February, 2018. Before joining Legend Biotech, Dr Xu was Senior Vice President at Merck where she led teams in biologics and vaccines discovery, development, and commercialization. Prior to Merck, Dr Xu held positions at Gilead, Novartis, Amgen, Chiron, GlaxoSmithKline, and Genentech.
With more than 25 years of biologic, biosimilar, vaccine and cell therapy discovery, development, commercialization, and life-cycle-management experience, Dr Xu has contributed to the successful commercial launch of nearly 25 products.
Dr Xu received her Bachelor of Science in biochemistry from Nanjing University, China, her Doctor of Philosophy in biochemistry from the University of Maryland at College Park in College Park, Maryland, USA, and completed her post-degree training in virology and gene therapy at the University of California, San Diego in San Diego, California, USA.